HIV Research Today is a free monthly online journal that collates and summarizes the latest research about HIV, including details on human immunodeficiency virus, testing, treatment, prevention, vaccines, aids.

Volume 4 (2007), Issue 2 (February)

1. Herpes simplex virus type 2 and risk of intrapartum human immunodeficiency virus transmission.
   Obstet Gynecol, 109(2): 403-9. [Abstract] [Full-text]
2. Fetal fibronectin and adverse infant outcomes in a predominantly human immunodeficiency virus-infected African population: a randomized controlled trial.
   Obstet Gynecol, 109(2): 392-401. [Abstract] [Full-text]
3. Management of AIDS-related Kaposi's sarcoma.
   Lancet Oncol, 8(2): 167-76. [Abstract] [Full-text]
4. Perceptions of health and self-care learning needs of outpatients with HIV/AIDS.
   J Community Health Nurs, 24(1): 49-64. [Abstract] [Full-text]
5. Surgeons are failing to recognize children with HIV infection.
   J Pediatr Surg, 42(2): 431-4. [Abstract] [Full-text]
6. Frequent needle exchange use and HIV incidence in Vancouver, Canada.
   Am J Med, 120(2): 172-9. [Abstract] [Full-text]
7. Evidence of ongoing immune reconstitution in subjects with sustained viral suppression following 6 years of lopinavir-ritonavir treatment.
   Clin Infect Dis, 44(5): 749-54. [Abstract] [Full-text]
8. The incidence and natural history of osteonecrosis in HIV-infected adults.
   Clin Infect Dis, 44(5): 739-48. [Abstract] [Full-text]
9. Metabolic syndrome in HIV-infected patients from an urban, midwestern US outpatient population.
   Clin Infect Dis, 44(5): 726-34. [Abstract] [Full-text]
10. Maintenance of endemicity in urban environments: a hypothesis linking risk, network structure and geography.
    Sex Transm Infect, 83(1): 10-5. [Abstract] [Full-text]
11. Why are children still being infected with HIV? Experiences in the prevention of mother-to-child transmission of HIV in south London.
    Sex Transm Infect, 83(1): 59-63. [Abstract] [Full-text]
12. Is smoking tobacco an independent risk factor for HIV infection and progression to AIDS? A systemic review.
    Sex Transm Infect, 83(1): 41-6. [Abstract] [Full-text]
13. Disclosure of HIV status to sex partners and sexual risk behaviours among HIV-positive men and women, Cape Town, South Africa.
    Sex Transm Infect, 83(1): 29-34. [Abstract] [Full-text]
14. The validity of self-reported likelihood of HIV infection among the general population in rural Malawi.
    Sex Transm Infect, 83(1): 35-40. [Abstract] [Full-text]
15. Trends in HIV testing, serial HIV prevalence and HIV incidence among people attending a Center for AIDS Prevention from 1988 to 2003.
    Sex Transm Infect, 83(1): 23-8. [Abstract] [Full-text]
16. Testosterone supplementation of megestrol therapy does not enhance lean tissue accrual in men with human immunodeficiency virus-associated weight loss: a randomized, double-blind, placebo-controlled, multicenter trial.
    J Clin Endocrinol Metab, 92(2): 563-70. [Abstract] [Full-text]
17. Prevalence of anemia and correlation with biomarkers and specific antiretroviral regimens in 9690 human-immunodeficiency-virus-infected patients: findings of the Anemia Prevalence Study.
    Curr Med Res Opin, 23(2): 343-55. [Abstract] [Full-text]
18. Methylation: a regulator of HIV-1 replication?
    Retrovirology, 4: 9. [Abstract] [Full-text]
19. Effect of chloroquine on reducing HIV-1 replication in vitro and the DC-SIGN mediated transfer of virus to CD4+ T-lymphocytes.
    Retrovirology, 4: 6. [Abstract] [Full-text]
20. Self-reported hepatitis B and C virus infections had low sensitivity among HIV-infected patients.
    J Clin Epidemiol, 60(3): 294-9. [Abstract] [Full-text]
21. Dendritic cell-mediated trans-enhancement of human immunodeficiency virus type 1 infectivity is independent of DC-SIGN.
    J Virol, 81(5): 2519-23. [Abstract] [Full-text]
22. CD8 T-cell recognition of multiple epitopes within specific Gag regions is associated with maintenance of a low steady-state viremia in human immunodeficiency virus type 1-seropositive patients.
    J Virol, 81(5): 2440-8. [Abstract] [Full-text]
23. Reduced maximal inhibition in phenotypic susceptibility assays indicates that viral strains resistant to the CCR5 antagonist maraviroc utilize inhibitor-bound receptor for entry.
    J Virol, 81(5): 2359-71. [Abstract] [Full-text]
24. Preferential infection of dendritic cells during human immunodeficiency virus type 1 infection of blood leukocytes.
    J Virol, 81(5): 2297-306. [Abstract] [Full-text]
25. Intracellular Tat of human immunodeficiency virus type 1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus: role of JAK/STAT signaling.
    J Virol, 81(5): 2401-17. [Abstract] [Full-text]
26. Isolation and characterization of replication-competent human immunodeficiency virus type 1 from a subset of elite suppressors.
    J Virol, 81(5): 2508-18. [Abstract] [Full-text]
27. Fitness landscape of human immunodeficiency virus type 1 protease quasispecies.
    J Virol, 81(5): 2485-96. [Abstract] [Full-text]
28. CD4 coexpression regulates DC-SIGN-mediated transmission of human immunodeficiency virus type 1.
    J Virol, 81(5): 2497-507. [Abstract] [Full-text]
29. Neuropsychological abnormalities in patients with dementia in CRF 01_AE HIV-1 infection.
    Neurology, 68(7): 525-7. [Abstract] [Full-text]
30. Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial.
    Neurology, 68(7): 515-21. [Abstract] [Full-text]
31. West Nile virus infection presenting as acute flaccid paralysis in an HIV-infected patient: a case report and review of the literature.
    Neurology, 68(7): E5-7. [Abstract] [Full-text]
32. Rev-dependent lentiviral expression vector.
    Retrovirology, 4: 12. [Abstract] [Full-text]
33. Analysis of the replication of HIV-1 forced to use tRNAMet(i) supports a link between primer selection, translation and encapsidation.
    Retrovirology, 4: 10. [Abstract] [Full-text]
34. Structural definition of a conserved neutralization epitope on HIV-1 gp120.
    Nature, 445(7129): 732-7. [Abstract] [Full-text]
35. HIV/AIDS and TB: contextual issues and policy choice in programme relationships.
    Trop Med Int Health, 12(2): 183-94. [Abstract] [Full-text]
36. Female sex workers and unsafe sex in urban and rural Nyanza, Kenya: regular partners may contribute more to HIV transmission than clients.
    Trop Med Int Health, 12(2): 174-82. [Abstract] [Full-text]
37. Rapid point-of-care HIV testing in pregnant women: a systematic review and meta-analysis.
    Trop Med Int Health, 12(2): 162-73. [Abstract] [Full-text]
38. HIV infection presenting in older children and adolescents: a case series from Harare, Zimbabwe.
    Clin Infect Dis, 44(6): 874-8. [Abstract] [Full-text]
39. Bilateral Bell palsy and acute HIV type 1 infection: report of 2 cases and review.
    Clin Infect Dis, 44(6): e57-61. [Abstract] [Full-text]
40. The road to chromatin - nuclear entry of retroviruses.
    Nat Rev Microbiol, 5(3): 187-96. [Abstract] [Full-text]
41. The AmRo study: pregnancy outcome in HIV-1-infected women under effective highly active antiretroviral therapy and a policy of vaginal delivery.
    BJOG, 114(2): 148-55. [Abstract] [Full-text]
42. Small-angle X-ray characterization of the nucleoprotein complexes resulting from DNA-induced oligomerization of HIV-1 integrase.
    Nucleic Acids Res, 35(3): 975-87. [Abstract] [Full-text]
43. Abacavir sulfate/lamivudine/zidovudine fixed combination in the treatment of HIV infection.
    Expert Opin Pharmacother, 8(4): 477-83. [Abstract] [Full-text]
44. Investigating the "steric gate" of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase by targeted insertion of unnatural amino acids.
    Biochemistry, 46(8): 2118-26. [Abstract] [Full-text]
45. Leukocyte-specific protein 1 interacts with DC-SIGN and mediates transport of HIV to the proteasome in dendritic cells.
    J Exp Med, 204(2): 421-30. [Abstract] [Full-text]
46. Noninfectious papilloma virus-like particles inhibit HIV-1 replication: implications for immune control of HIV-1 infection by IL-27.
    Blood, 109(5): 1841-9. [Abstract] [Full-text]
47. Postgenomic up-regulation of CCL3L1 expression in HTLV-2-infected persons curtails HIV-1 replication.
    Blood, 109(5): 1850-6. [Abstract] [Full-text]
48. Cytotoxic CD4+ T cells use granulysin to kill Cryptococcus neoformans, and activation of this pathway is defective in HIV patients.
    Blood, 109(5): 2049-57. [Abstract] [Full-text]
49. Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus.
    N Engl J Med, 356(8): 790-9. [Abstract] [Full-text]
50. Socioeconomic differences in the impact of HIV infection on workforce participation in France in the era of highly active antiretroviral therapy.
    Am J Public Health, 97(3): 552-8. [Abstract] [Full-text]
51. Evolution of China's response to HIV/AIDS.
    Lancet, 369(9562): 679-90. [Abstract] [Full-text]
52. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial.
    Lancet, 369(9562): 657-66. [Abstract] [Full-text]
53. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial.
    Lancet, 369(9562): 643-56. [Abstract] [Full-text]
54. Epstein Barr virus genotypes and LMP-1 variants in HIV-infected patients.
    J Med Virol, 79(4): 401-7. [Abstract] [Full-text]
55. Extensive cross-reactive neutralizing antibody response in Indian patients with limited genetic diversity of HIV-1.
    Virology, 359(2): 295-301. [Abstract] [Full-text]
56. The Vif accessory protein alters the cell cycle of human immunodeficiency virus type 1 infected cells.
    Virology, 359(2): 243-52. [Abstract] [Full-text]
57. Targeting potential and anti-HIV activity of lamivudine loaded mannosylated poly (propyleneimine) dendrimer.
    Biochim Biophys Acta, 1770(4): 681-6. [Abstract] [Full-text]
58. Superiority of infectivity-based over particle-based methods for quantitation of drug resistant HIV-1 as inocula for cell cultures.
    J Virol Methods, 141(1): 87-96. [Abstract] [Full-text]
59. Evaluation of performance across the dynamic range of the Abbott RealTime HIV-1 assay as compared to VERSANT HIV-1 RNA 3.0 and AMPLICOR HIV-1 MONITOR v1.5 using serial dilutions of 39 group M and O viruses.
    J Virol Methods, 141(1): 49-57. [Abstract] [Full-text]
60. Effect of cytomegalovirus retinitis on the risk of visual acuity loss among patients with AIDS.
    Ophthalmology, 114(3): 591-8. [Abstract] [Full-text]
61. HIV and syphilis: when to perform a lumbar puncture.
    Sex Transm Dis, 34(3): 141-4. [Abstract] [Full-text]
62. The testis and epididymis are productively infected by SIV and SHIV in juvenile macaques during the post-acute stage of infection.
    Retrovirology, 4: 7. [Abstract] [Full-text]

© 2004-2008 HIV Research Today. All Rights Reserved.